Institutional Ownership Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX). We have compiled data on the 220 institutions that hold shares in the stock, with a total of 75.8 Million shares, which have been reported (via 13F filing form) to have a value of $3.37 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
5,436,104
shares
|
$241 Million
0.01% of portfolio
|
Q1 2024
Added 1.7%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
May 15, 2024 Q1 2024 |
5,226,297
shares
|
$232 Million
2.68% of portfolio
|
Q1 2024
Added 3.7%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2024 Q1 2024 |
4,949,486
shares
|
$220 Million
0.59% of portfolio
|
Q1 2024
Added 44.85%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
May 15, 2024 Q1 2024 |
4,155,375
shares
|
$185 Million
5.55% of portfolio
|
Q1 2024
Added 106.48%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
3,823,218
shares
|
$170 Million
0.02% of portfolio
|
Q1 2024
Added 27.07%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
3,575,076
shares
|
$159 Million
0.0% of portfolio
|
Q1 2024
Added 2.07%
|
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
3,255,253
shares
|
$145 Million
0.01% of portfolio
|
Q1 2024
Reduced 8.66%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
May 15, 2024 Q1 2024 |
3,124,749
shares
|
$139 Million
5.49% of portfolio
|
Q1 2024
Added 35.1%
|
|
|
Wellington Management Group LLP
Boston, MA |
May 15, 2024 Q1 2024 |
2,971,582
shares
|
$132 Million
0.03% of portfolio
|
Q1 2024
New holding
|
|
|
Jennison Associates LLC
|
May 02, 2024 Q1 2024 |
2,817,854
shares
|
$125 Million
0.09% of portfolio
|
Q1 2024
Added 10.6%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 15, 2024 Q1 2024 |
2,654,729
shares
|
$118 Million
0.08% of portfolio
|
Q1 2024
Added 9.81%
|
|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2024 Q1 2024 |
1,978,172
shares
|
$87.9 Million
0.05% of portfolio
|
Q1 2024
Added 264.13%
|
|
|
First Light Asset Management, LLC
Edina, MN |
May 15, 2024 Q1 2024 |
1,690,177
shares
|
$75.1 Million
6.19% of portfolio
|
Q1 2024
Reduced 14.97%
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
1,476,203
shares
|
$65.6 Million
1.45% of portfolio
|
Q1 2024
Added 17.58%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
1,401,403
shares
|
$62.2 Million
0.01% of portfolio
|
Q1 2024
Added 3.6%
|
|
|
Artal Group S.A.
Luxembourg, N4 |
May 17, 2024 Q1 2024 |
1,390,477
shares
|
$61.8 Million
3.51% of portfolio
|
Q1 2024
New holding
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
1,385,000
shares
|
$61.5 Million
1.46% of portfolio
|
Q1 2024
Reduced 16.93%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
May 15, 2024 Q1 2024 |
1,150,000
shares
|
$51.1 Million
3.1% of portfolio
|
Q4 2023
Added 4.36%
|
|
|
Novo Holdings
Hellerup, G7 |
May 15, 2024 Q1 2024 |
1,098,600
shares
|
$48.8 Million
4.17% of portfolio
|
Q1 2024
Reduced 0.13%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
May 15, 2024 Q1 2024 |
1,059,633
shares
|
$47.1 Million
0.8% of portfolio
|
Q4 2023
Added 4.01%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
May 09, 2024 Q1 2024 |
964,568
shares
|
$42.8 Million
0.15% of portfolio
|
Q1 2024
Added 24.09%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
864,107
shares
|
$38.4 Million
0.01% of portfolio
|
Q1 2024
Added 32.9%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
May 15, 2024 Q1 2024 |
660,143
shares
|
$29.3 Million
12.39% of portfolio
|
Q1 2024
Reduced 16.13%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 16, 2024 Q1 2024 |
643,751
shares
|
$28.6 Million
4.0% of portfolio
|
Q1 2024
Reduced 5.38%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 10, 2024 Q1 2024 |
640,802
shares
|
$28.5 Million
0.01% of portfolio
|
Q1 2024
Reduced 2.9%
|
|